Eline Houben

PHARMO Institute, Netherlands

Poster(s):

• (C-237) Assessing the Risk of Angioedema in Adult Sacubitril/Valsartan Users With Heart Failure: Results From a Post-Authorization Safety Study in Seven European Electronic Healthcare Databases
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (B-239) Incidence of post-partum hemorrhage and amount of blood loss in the Netherlands
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (SLB-036) Investigating Potential Drug-Drug-Interactions Between Sacubitril/Valsartan and Statins and the Risk of Myotoxicity, Hepatotoxicity or Acute Pancreatitis: A Post-Authorisation Safety Study in 7 European Healthcare Databases
  Monday, August 25, 2025

  11:45 AM - 12:45 PM ET

• (B-276) Paternal Linkage in the PHARMO Data Network: Assessing the Impact of Paternal Drug Exposure on Child Health Outcomes
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-023) Studying paternal drug exposures and offspring outcomes: feasibility assessment of large European databases
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET